Unknown

Dataset Information

0

Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death.


ABSTRACT: Salinomycin has been used as treatment for malignant tumors in a small number of humans, causing far less side effects than standard chemotherapy. Several studies show that Salinomycin targets cancer-initiating cells (cancer stem cells, or CSC) resistant to conventional therapies. Numerous studies show that Salinomycin not only reduces tumor volume, but also decreases tumor recurrence when used as an adjuvant to standard treatments. In this study we show that starvation triggered different stress responses in cancer cells and primary normal cells, which further improved the preferential targeting of cancer cells by Salinomycin. Our in vitro studies further demonstrate that the combined use of 2-Fluoro 2-deoxy D-glucose, or 2-deoxy D-glucose with Salinomycin is lethal in cancer cells while the use of Oxamate does not improve cell death-inducing properties of Salinomycin. Furthermore, we show that treatment of cancer cells with Salinomycin under starvation conditions not only increases the apoptotic caspase activity, but also diminishes the protective autophagy normally triggered by the treatment with Salinomycin alone. Thus, this study underlines the potential use of Salinomycin as a cancer treatment, possibly in combination with short-term starvation or starvation-mimicking pharmacologic intervention.

SUBMITTER: Jangamreddy JR 

PROVIDER: S-EPMC4496345 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death.

Jangamreddy Jaganmohan R JR   Jain Mayur V MV   Hallbeck Anna-Lotta AL   Roberg Karin K   Lotfi Kourosh K   Łos Marek J MJ  

Oncotarget 20150401 12


Salinomycin has been used as treatment for malignant tumors in a small number of humans, causing far less side effects than standard chemotherapy. Several studies show that Salinomycin targets cancer-initiating cells (cancer stem cells, or CSC) resistant to conventional therapies. Numerous studies show that Salinomycin not only reduces tumor volume, but also decreases tumor recurrence when used as an adjuvant to standard treatments. In this study we show that starvation triggered different stres  ...[more]

Similar Datasets

| S-EPMC7595060 | biostudies-literature
| S-EPMC3943874 | biostudies-literature
| S-EPMC5378984 | biostudies-literature
| S-EPMC7080508 | biostudies-literature
| S-EPMC8600073 | biostudies-literature
| S-EPMC2267501 | biostudies-other
| S-EPMC3722315 | biostudies-literature
| S-EPMC8706473 | biostudies-literature
| S-EPMC7261383 | biostudies-literature
| S-EPMC8786886 | biostudies-literature